1. Home
  2. PKE vs NMRA Comparison

PKE vs NMRA Comparison

Compare PKE & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Park Aerospace Corp.

PKE

Park Aerospace Corp.

HOLD

Current Price

$24.57

Market Cap

463.2M

Sector

Industrials

ML Signal

HOLD

NMRA

Neumora Therapeutics Inc.

HOLD

Current Price

$2.07

Market Cap

424.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
PKE
NMRA
Founded
1954
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Military/Government/Technical
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
463.2M
424.4M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
PKE
NMRA
Price
$24.57
$2.07
Analyst Decision
Buy
Analyst Count
0
9
Target Price
N/A
$8.00
AVG Volume (30 Days)
296.4K
2.4M
Earning Date
01-13-2026
03-02-2026
Dividend Yield
1.98%
N/A
EPS Growth
19.30
N/A
EPS
0.43
N/A
Revenue
$66,053,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$58.81
N/A
Revenue Growth
7.54
N/A
52 Week Low
$11.97
$0.61
52 Week High
$26.12
$3.25

Technical Indicators

Market Signals
Indicator
PKE
NMRA
Relative Strength Index (RSI) 59.73 51.18
Support Level $24.15 $1.84
Resistance Level $26.00 $2.18
Average True Range (ATR) 1.33 0.24
MACD 0.09 0.01
Stochastic Oscillator 61.61 52.34

Price Performance

Historical Comparison
PKE
NMRA

About PKE Park Aerospace Corp.

Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Share on Social Networks: